Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:2431-2436

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorostkar, P. C.
Right arrow Articles by Scheinman, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorostkar, P. C.
Right arrow Articles by Scheinman, M. M.

(Circulation. 1999;100:2431.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With ß-Blockers and Continuous Pacing

Parvin C. Dorostkar, MD, MS; Michael Eldar, MD; Bernard Belhassen, MD; Melvin M. Scheinman, MD

From the Divisions of Electrophysiology and Pediatric Cardiology, University of California, San Francisco.

Correspondence to Parvin C. Dorostkar, MD, Division of Pediatric Cardiology, Rainbow Babies and Children’s Hospital, 11100 Euclid Ave, Cleveland, OH 44106.

Background—The long-QT syndrome is associated with sudden cardiac death. Combination of ß-blocker and pacing therapy has been proposed for treatment of drug-resistant patients. The purpose of this study was to summarize our long-term experience with combined therapy in patients with long-QT syndrome.

Methods and Results—A total of 37 patients with idiopathic long-QT syndrome were treated with combined therapy consisting of continuous cardiac pacing and maximally tolerated ß-blocker therapy and followed up for 6.3±4.6 years (mean±SD). The group consisted of 32 female and 5 male patients with a mean age of 31.6 years. The mean paced rate was 82±7 bpm (range, 60 to 100 bpm). On follow-up, recurrent symptoms caused by pacemaker malfunction were documented in 3 patients. Four patients died during the follow-up period: 2 adolescents stopped ß-blocker therapy, 1 patient died suddenly while treated with combined therapy, and 1 patient died of unrelated causes. In addition, 3 patients had resuscitated cardiac arrest while on combined therapy, and 1 patient had repeated, appropriate implantable cardioverter-defibrillator discharges on follow-up.

Conclusions—Because 28 of 37 patients remain without symptoms with ß-blocker therapy and continuous pacing, combined therapy appears to provide reasonable, long-term control for this high-risk group. However, the incidence of sudden death and aborted sudden death (24% in all patients and 17% in compliant patients) strongly suggests the use of a "back-up" defibrillator, particularly in noncompliant adolescent patients. Implantable cardioverter-defibrillator therapy, however, may be associated with recurrent shocks in susceptible patients.


Key Words: syncope • death, sudden • cardioversion • defibrillation • pacemakers




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
I. Goldenberg and A. J. Moss
Long QT syndrome.
J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2291 - 2300.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
EuropaceHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Europace, October 1, 2007; 9(10): 959 - 998.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al.
Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association
Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295.
[Full Text] [PDF]


Home page
CirculationHome page
E. A. Stephenson and C. I. Berul
Electrophysiological Interventions for Inherited Arrhythmia Syndromes
Circulation, August 28, 2007; 116(9): 1062 - 1080.
[Full Text] [PDF]


Home page
CirculationHome page
R. Passman and A. Kadish
Sudden Death Prevention With Implantable Devices
Circulation, July 31, 2007; 116(5): 561 - 571.
[Full Text] [PDF]


Home page
CirculationHome page
H. L. Tan, A. Bardai, W. Shimizu, A. J. Moss, E. Schulze-Bahr, T. Noda, and A. A. M. Wilde
Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications
Circulation, November 14, 2006; 114(20): 2096 - 2103.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Viitasalo, L. Oikarinen, H. Swan, H. Vaananen, J. Jarvenpaa, H. Hietanen, J. Karjalainen, and L. Toivonen
Effects of Beta-Blocker Therapy on Ventricular Repolarization Documented by 24-h Electrocardiography in Patients With Type 1 Long-QT Syndrome
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
M C S Hall and D M Todd
Modern management of arrhythmias
Postgrad. Med. J., February 1, 2006; 82(964): 117 - 125.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. D. Krahn, M. Gollob, R. Yee, L. J. Gula, A. C. Skanes, B. D. Walker, and G. J. Klein
Diagnosis of Unexplained Cardiac Arrest: Role of Adrenaline and Procainamide Infusion
Circulation, October 11, 2005; 112(15): 2228 - 2234.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A J Turley, J Thambyrajah, and A A Harcombe
Bilateral thoracoscopic cervical sympathectomy for the treatment of recurrent polymorphic ventricular tachycardia
Heart, January 1, 2005; 91(1): 15 - 17.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. J. Moss
Long QT Syndrome
JAMA, April 23, 2003; 289(16): 2041 - 2044.
[Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. Nemec, J. B. Hejlik, W.-K. Shen, and M. J. Ackerman
Catecholamine-Induced T-Wave Lability in Congenital Long QT Syndrome: A Novel Phenomenon Associated With Syncope and Cardiac Arrest
Mayo Clin. Proc., January 1, 2003; 78(1): 40 - 50.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
X. H.T. Wehrens, M. A. Vos, P. A. Doevendans, and H. J.J. Wellens
Novel Insights in the Congenital Long QT Syndrome
Ann Intern Med, December 17, 2002; 137(12): 981 - 992.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Nagatomo, C. T. January, B. Ye, H. Abe, Y. Nakashima, and J. C. Makielski
Rate-dependent QT shortening mechanism for the LQT3 {Delta}KPQ mutant
Cardiovasc Res, June 1, 2002; 54(3): 624 - 629.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
R. Chatrath, C.-b. J. Porter, and M. J. Ackerman
Role of Transvenous Implantable Cardioverter-Defibrillators in Preventing Sudden Cardiac Death in Children, Adolescents, and Young Adults
Mayo Clin. Proc., March 1, 2002; 77(3): 226 - 231.
[Abstract] [PDF]


Home page
HeartHome page
B Campanelli and J-M Chaudron
Long term follow up of long QT syndrome treated by overdrive pacing
Heart, November 1, 2001; 86(5): e14 - 14.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. V. Exner, G. J. Klein, and E. N. Prystowsky
Primary Prevention of Sudden Death With Implantable Defibrillator Therapy in Patients With Cardiac Disease: Can We Afford to Do It? (Can We Afford Not To?)
Circulation, September 25, 2001; 104(13): 1564 - 1570.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]


Home page
HeartHome page
S Viskin, R Fish, D Zeltser, B Belhassen, K Heller, D Brosh, S Laniado, and H V Barron
Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent?
Heart, June 1, 2000; 83(6): 661 - 666.
[Abstract] [Full Text]


Home page
Journal Watch CardiologyHome page
ICDs for Long QT Syndrome After Failed Beta-Blocker Therapy
Journal Watch Cardiology, January 21, 2000; 2000(121): 9 - 9.
[Full Text]